PCG
Private Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,083
| Closed | -$97K | – | 2141 |
|
|
2022
Q1 | $97K | Hold |
1,083
| – | – | 0.02% | 407 |
|
|
2021
Q4 | $121K | Hold |
1,083
| – | – | 0.03% | 368 |
|
|
2021
Q3 | $136K | Hold |
1,083
| – | – | 0.03% | 321 |
|
|
2021
Q2 | $147K | Hold |
1,083
| – | – | 0.03% | 288 |
|
|
2021
Q1 | $147K | Hold |
1,083
| – | – | 0.04% | 279 |
|
|
2020
Q4 | $153K | Hold |
1,083
| – | – | 0.03% | 373 |
|
|
2020
Q3 | $121K | Hold |
1,083
| – | – | 0.03% | 399 |
|
|
2020
Q2 | $121K | Hold |
1,083
| – | – | 0.03% | 391 |
|
|
2020
Q1 | $84K | Hold |
1,083
| – | – | 0.02% | 453 |
|
|
2019
Q4 | $103K | Sell |
1,083
-3,360
| -76% | -$320K | 0.02% | 442 |
|
|
2019
Q3 | $339K | Sell |
4,443
-2,150
| -33% | -$164K | 0.06% | 186 |
|
|
2019
Q2 | $628K | Buy |
6,593
+1,295
| +24% | +$123K | 0.14% | 106 |
|
|
2019
Q1 | $480K | Sell |
5,298
-258
| -5% | -$23.4K | 0.09% | 143 |
|
|
2018
Q4 | $399K | Sell |
5,556
-1,017
| -15% | -$73K | 0.09% | 149 |
|
|
2018
Q3 | $630K | Sell |
6,573
-20
| -0.3% | -$1.92K | 0.13% | 122 |
|
|
2018
Q2 | $627K | Sell |
6,593
-500
| -7% | -$47.6K | 0.14% | 114 |
|
|
2018
Q1 | $622K | Buy |
7,093
+6,268
| +760% | +$550K | 0.14% | 112 |
|
|
2017
Q4 | $34 | Buy |
+825
| New | +$34 | 0.01% | 847 |
|